DarioHealth reports preliminary Q2 revenue $6.0-6.15M, new health plan contract for 160K hypertension members

DarioHealth Corp.

Preliminary Q2 2023 revenue $6.0-6.15M, driven by B2B channel growth for 10th consecutive quarter.
Preliminary six-month revenue $13-13.15M; cash and equivalents $52.6M as of June 30, 2023.
New agreement with large regional health plan to provide hypertension digital solution to over 160,000 members, launching July 2023.
Strategic partnerships with MedOne (attributed to Sanofi) and Plan (attributed to Solera) expected to contribute to 2023 revenue.
Private-labeled Aetna platform delivered on schedule; member enrollment expected in 2024.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

DarioHealth Corp. reported second quarter ended June 30, 2023 results: revenue between $6.0 million and $6.15 million.

Period: second quarter ended June 30, 2023
Revenue: between $6.0 million and $6.15 million
Result: preliminary results

Exact text from the filing

Dario also announced today preliminary unaudited revenue results for the three months ended June 30, 2023 of between $6.0 million and $6.15 million

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

DarioHealth Corp. filing history →

Source: SEC EDGAR

accession 0001104659-23-083237

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.